ProfileGDS4459 / ENSG00000138433
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 78% 77% 79% 55% 81% 79% 79% 82% 80% 74% 78% 80% 82% 81% 78% 70% 77% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.7678
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.6277
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.0979
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.6655
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.2881
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.9479
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.1479
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.3682
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.2880
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.6974
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.9378
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.2580
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.3382
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.9781
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.0778
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.270
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.7477